H15.129

Clinical Causes: Autoimmune disorders such as rheumatoid arthritis or lupus Infections, including bacterial or viral conjunctivitis Response to medications or inflammatory reactions Idiopathic cases where no specific cause is identified Associated systemic diseases or conditions

Key Symptoms: Localized redness, often appearing as a well-defined area on the sclera presence of a nodular or lump-like swelling on the eye surface Mild to moderate eye discomfort or pain Sensitivity to light (photophobia) Tearing or watery eyes Possible blurred vision if inflammation affects visual axis

Diagnosis Path: Diagnosis of nodular episcleritis typically involves a comprehensive eye examination by an ophthalmologist. The clinician will look for characteristic signs such as localized redness and nodular swelling. Additional assessments, including the use of specialized dyes like fluorescein to rule out corneal involvement and tests to identify underlying systemic conditions, may be conducted. In some cases, additional diagnostic procedures, including blood tests, are employed to explore potential systemic causes.

Treatment Protocols: Management of nodular episcleritis focuses on alleviating symptoms and addressing underlying causes. Treatment options generally include: - **Topical medications:** Non-steroidal anti-inflammatory drugs (NSAIDs) eye drops or corticosteroid eye drops to reduce inflammation. - **Systemic medications:** In more severe or recurrent cases, oral NSAIDs or corticosteroids may be prescribed. - **Monitoring:** Regular follow-up appointments to observe disease progression or resolution. - **Addressing underlying issues:** If associated with systemic autoimmune or infectious conditions, appropriate treatment of those conditions is important. Most cases of nodular episcleritis resolve with appropriate therapy and do not lead to serious complications. However, prompt medical consultation is recommended if symptoms worsen or persist.